ISTH Welcomes Flora Peyvandi as President for 2022-2024 Term

CHAPEL HILL, NC, USA The International Society on Thrombosis and Haemostasis (ISTH), welcomes Flora Peyvandi, M.D., Ph.D., as ISTH President for the 2022-2024 term. Peyvandi is a professor of internal medicine at the University of Milan and the Director of the Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center at the Internal Medicine-Hemostasis and Thrombosis Unit of the IRCCS Maggiore Hospital in Milan, Italy.

For the next two years, Peyvandi will fill the role of President-Elect, working closely with incoming ISTH President, Jeffrey Weitz, M.D., to support the ISTH Council and provide direction on the activities for the Society in accordance to the Society’s bylawsFollowing her role as President-Elect, Peyvandi will assume the role of ISTH President at the ISTH 2022 Congress in London, England.

“We are proud to announce the appointment of Flora  Peyvandi to this pivotal role at the ISTH,” said outgoing ISTH President Jeff Weitz, M.D. “Her long history of outstanding research and leadership in the thrombosis and hemostasis community will propel the Society forward with tremendous momentum. Her guidance of education and global community-building will positively impact the lives of patients around the world.”

Peyvandi has dedicated her career to bringing state-of-the-art treatments and technologies into her research to offer patients cutting-edge therapeutic approaches. Her research, as highlighted by her numerous publications, has focused on the investigation of molecular mechanisms of coagulation disorders and on the immunogenicity of coagulation products. Peyvandi has served in many leadership roles across different international scientific societies focused on bleeding and clotting disorders. At the ISTH, Peyvandi has served on the Executive Committee and the Guidelines and Guidance Committee, and was chair of the Education Committee. She is also Co-Chair of Gene Therapy in Hemophilia: an ISTH Education Initiative as well as Co-Chair of the ISTH 2020 Congress in Milan.

“It is an honor to be elected ISTH president for the 2022-2024 term,” Peyvandi said. “Our plan is to build on the Society’s past successes and focus on keeping science at the core of all activities while strengthening the educational offerings in ways that will enhance clinical and laboratory research as well as patient care. This will ensure strong global leadership of the ISTH for years to come.”

To learn more about the ISTH, visit

About the International Society on Thrombosis and Haemostasis (ISTH)

Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosis and hemostasis. ISTH is an international medical-scientific professional membership organization with more than 7,500 clinicians, researchers, and educators working together to improve the lives of patients in more than 110 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees, and World Thrombosis Day on 13 October. Visit ISTH online at

Media Contact:

Melissa DiMercurio
Media Relations Manager
International Society on Thrombosis and Haemostasis (ISTH)




Previous Article Roles of Factor VIII in Endothelial Cell Biology More than a Coagulation Factor
Next Article New ISTH COVID-19 Guidelines Now Available